These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 2120551

  • 61. [Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella].
    Trier H, Rønne T.
    Ugeskr Laeger; 1992 Jul 13; 154(29):2008-13. PubMed ID: 1509566
    [Abstract] [Full Text] [Related]

  • 62. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases.
    Vaccine; 1998 May 13; 16(8):818-22. PubMed ID: 9627939
    [Abstract] [Full Text] [Related]

  • 63. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 64. [The immunological efficacy of the combined vaccine Trimovax intended for the prevention of measles, mumps and rubella].
    Samoĭlovich EO, Kapustik LA, Fel'dman EV, Ermolovich MA, Svirchevskaia EIu, Titov LP, Zakharenko DF, Belova EIu, Chernovetskiĭ MA, Korostik TS.
    Zh Mikrobiol Epidemiol Immunobiol; 1998 Jun 10; (4):36-40. PubMed ID: 9783398
    [Abstract] [Full Text] [Related]

  • 65. Vaccination against measles, mumps and rubella (MMR): a comparison between the antibody responses at the ages of 18 months and 12 years and between different methods of antibody titration.
    Christenson B, Böttiger M.
    J Biol Stand; 1985 Apr 10; 13(2):167-72. PubMed ID: 3997899
    [Abstract] [Full Text] [Related]

  • 66. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B, Smerdel S, Abu Eldan J, Kolić J, Ferdebar M, Kordić D, Mohacek N.
    Lijec Vjesn; 1989 Apr 10; 111(4-5):131-4. PubMed ID: 2770398
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L, Germann D, Bally F, Schopfer K.
    Eur J Epidemiol; 1997 Jan 10; 13(1):61-6. PubMed ID: 9062781
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.
    Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835
    [Abstract] [Full Text] [Related]

  • 72. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S, Cordero-Yap L, Lu-Fong M, Soriano R, Ludan A, Chitour K, Bock HL.
    Southeast Asian J Trop Med Public Health; 1999 Sep 28; 30(3):511-7. PubMed ID: 10774661
    [Abstract] [Full Text] [Related]

  • 73. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M, Berger R, Just V.
    Dev Biol Stand; 1986 Sep 28; 65():85-8. PubMed ID: 3030863
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M, Smerdel S, Dedić I, Delimar N, Rajninger-Miholic M, Juzbasić M, Manhalter T, Vlatković R, Borcić B, Mihajić Z.
    Dev Biol Stand; 1986 Sep 28; 65():95-100. PubMed ID: 3556780
    [Abstract] [Full Text] [Related]

  • 78. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P.
    Ann Ig; 1998 Sep 28; 10(1):19-24. PubMed ID: 9616974
    [No Abstract] [Full Text] [Related]

  • 79. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
    Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM.
    J Infect Dis; 2001 Oct 01; 184(7):817-26. PubMed ID: 11528592
    [Abstract] [Full Text] [Related]

  • 80. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM, Saunders EF, Petric M, Gold R.
    Bone Marrow Transplant; 1996 Apr 01; 17(4):633-6. PubMed ID: 8722367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.